Problem

Solutions

More financing is needed for candidate drugs

Further investment in neuroscience development

More patients are needed to participate in clinical trials

Ability to perform more decentralized neurological disease clinical trials

Need for better screening solutions in clinical trials

More sensitive biomarkers to reduce screening failure rate and identify patients who are a good fit

Need for improved data collection during drug trials to prove drug efficacy

More robust, granular data to assess small, intraindividual changes in neurocognitive function longitudinally

Altoida’s mission is to accelerate and improve drug development, neurological disease research, and patient care. To learn more about our precision-neurology platform and app-based medical device, contact us!

Contact Us